WAP
TXMD icon

Wealthcare Advisory Partners’s TherapeuticsMD TXMD Stock Holding History

Wealthcare Advisory Partners’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6
Closed – – 1273
2020
Q1 		$0 Hold
6
– – ﹤0.01% 1590
2019
Q4 		$1K Hold
6
– – ﹤0.01% 1351
2019
Q3 		$1K Hold
6
– – ﹤0.01% 1308
2019
Q2 		$1K Hold
6
– – ﹤0.01% 1276
2019
Q1 		$1K Buy
+6
New +$1.59K ﹤0.01% 1179

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wealthcare Advisory Partners's TXMD Position: Q2 2020 in Review

Wealthcare Advisory Partners sold out of TherapeuticsMD (TXMD) in Q2 2020, closing a stake of 6 shares.

Wealthcare Advisory Partners first reported a position in TXMD in Q1 2019 and held it in 5 quarters. The position peaked at $1K in Q4 2019. 149 funds tracked by Wall St. Rank hold TXMD as of Q2 2020.

  • Wealthcare Advisory Partners reported no remaining TherapeuticsMD position as of Q2 2020 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 6 TherapeuticsMD shares in Q2 2020.
  • Wealthcare Advisory Partners first reported a position in TherapeuticsMD in Q1 2019 and held it in 5 quarters.
  • Wealthcare Advisory Partners's TherapeuticsMD position peaked at $1K in Q4 2019.
  • 149 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2020.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2020, filed 29 Jul 2020.